All patients exhibit constitutive STAT1 and STAT3 phosphorylation, and the occurrence of STAT5B [19,20,21] and STAT3 [19,21,22,23] somatic activating mutations are a hallmark of LGL leukemia. The gene discussed is STAT3; the disease is T-cell large granular lymphocyte leukemia.